The linear range recommended by the sponsor for atorvastatin and p-hydroxyatorvastatin is too wide, and we cannot do it at present. If the sponsor thinks the low point is higher, we can modify the linearity to: 25 pg/mL~ 15000 pg/mL.
For the linear range proposed by the attovastatin and paracetatin bidders is too wide, we are not able to do so at present, if the bid party believes that the low point is high, we can modify the linearity to: 25 pg/mL to 15000 pg/mL.
For atorvastatin and p-hydroxy atorvastatin, the proposed linear range is too wide. At present, we can't do it. If the sponsor thinks that the low point is high, we can modify the linear range from 25 pg / ml to 15000 pg / ml.<br>